Abstract

Many orally administered drugs are marketed in sustained-release formulations. Manufacturers describe their products as long acting, or as gradual-, prolonged-, slow-, controlled- or timed-release. The British National Formulary refers to all of them as sustained-released (s/r) preparations. In this article we consider the place of such formulations.